FOCUS ASH 2012 ATLANTA
Actualités en Onco-Hématologie à l’ASH 2012
American Society of Hematology
8 au 11 décembre 2012 – Atlanta
LYMPHOMES AGRESSIFS
Quel PET Scan intermédiaire ?
jQuery(document).ready(function(){
// Get the video element that we wish to control
var iframe = document.getElementById('thevideo141883087');
// Initialize Froogaloop (linked .js.min file) on the captured video
var player_141883087 = $f(iframe);
// When a link with a class of "timecode" is clicked, capture the event
jQuery('.timecode_ac_id_141883087').on('click', function (e) {
jQuery('.timecode_ac_id_141883087').removeClass('activeli');
jQuery(this).addClass('activeli'); // Prevent the default link (typically a hash) from executing
e.preventDefault();
// Get the location value from the HTML5 data parameter
var seekVal = $(this).attr('data-seek'); jQuery('.timecode-ac141883087'+seekVal).addClass('activeli');
// Using Froogaloop, trigger the SeekTo method using the captured value
player_141883087.api('seekTo', seekVal);
});
});
Christian GISSELBRECHT, Paris
Quel serait l’intérêt en clinique de réaliser un PET Scan après 2 cycles de traitement, la réponse de Christian Gisselbrecht.